Pure and Organic CBD & and Hemp Products

Effective medicine provided by mother nature

  • Powerful relaxant

  • Strong painkiller

  • Stress reduction
  • Energy booster

Why CBD?

More and more renowned scientists worldwide publish their researches on the favorable impact of CBD on the human body. Not only does this natural compound deal with physical symptoms, but also it helps with emotional disorders. Distinctly positive results with no side effects make CBD products nothing but a phenomenal success.

This organic product helps cope with:

  • Tight muscles
  • Joint pain
  • Stress and anxiety
  • Depression
  • Sleep disorder

Range of Products

We have created a range of products so you can pick the most convenient ones depending on your needs and likes.

CBD Capsules Morning/Day/Night:

CBD Capsules

These capsules increase the energy level as you fight stress and sleep disorder. Only 1-2 capsules every day with your supplements will help you address fatigue and anxiety and improve your overall state of health.

Order Now

CBD Tincture

CBD Tincture

No more muscle tension, joints inflammation and backache with this easy-to-use dropper. Combined with coconut oil, CBD Tincture purifies the body and relieves pain. And the bottle is of such a convenient size that you can always take it with you.

Order Now

Pure CBD Freeze

Pure CBD Freeze

Even the most excruciating pain can be dealt with the help of this effective natural CBD-freeze. Once applied on the skin, this product will localize the pain without ever getting into the bloodstream.

Order Now

Pure CBD Lotion

Pure CBD Lotion

This lotion offers you multiple advantages. First, it moisturizes the skin to make elastic. And second, it takes care of the inflammation and pain. Coconut oil and Shia butter is extremely beneficial for the health and beauty of your skin.

Order Now


weight. Basic for 1-5 dosing mg and of body rule cats dogs: pounds every 10 for CBD



  • weight. Basic for 1-5 dosing mg and of body rule cats dogs: pounds every 10 for CBD
  • CBD Oil for Cats: Everything You Need To Know
  • Which CBD oil for your entire family does Dr Blake and his friends Yin and Yang recommend?
  • Basic dosing rule for cats and dogs: mg CBD for every 10 pounds of body weight. To control pain, give every 8 hours or as needed. BASIC DOSING RULE FOR DOGS and cats: MG CBD FOR EVERY 10 POUNDS OF BODY WEIGHT. To control pain, give every 8 hours or as needed. In this ultimate guide to CBD oil for dogs, cats, and other pets, Again, the mgs per 10 pounds of body weight rule applies. Be sure that you have correctly calculated how many milligrams of CBD is in each drop when using a tincture. 4 Corners Cannabis, the brand I use and trust, has these dosage.

    weight. Basic for 1-5 dosing mg and of body rule cats dogs: pounds every 10 for CBD

    Significant effects following inhaled doses were not observed due to delayed tasks administration 1. Oral cannabis administration impaired occasional cannabis users' performance on the OLS and WAT tasks compared to placebo, supporting other reports showing these tasks are sensitive to cannabis-related impairment.

    These are important public health policy findings as consumption of edible cannabis products increases. Schedules of Controlled Substances: Interim final rule, with request for comments. On July 1, , the U. Food and Drug Administration FDA approved a new drug application for Syndros, a drug product consisting of dronabinol [ - -deltatrans-tetrahydrocannabinol delta THC ] oral solution.

    Oral fluid OF cannabinoid testing, increasing in forensic and workplace settings, could be valuable for monitoring during cannabis treatment. There was a 5-puff smoked cannabis challenge on the 5th day. Each medication session was separated by 9 days of ad libitum cannabis smoking. CBN also decreased over time with concentrations fold lower than THC , with none detected beyond 69h.

    Higher cannabinoid concentrations following active oral THC administrations versus placebo suggest a compensatory effect of THC tolerance on smoking topography. Different doses of an adenosine A2A receptor antagonist MSX-3 [3,7-dihydro[ 1E 3-ethoxyphenyl ethenyl]-7 methyl[3- phosphooxy propyl 2 propynil -1H-purine-2,6-dione] were found previously to either decrease or increase self- administration of cannabinoids deltatetrahydrocannabinol THC or anandamide in squirrel monkeys.

    It was hypothesized that the decrease observed with a relatively low dose of MSX-3 was related to blockade of striatal presynaptic A2A receptors that modulate glutamatergic neurotransmission, whereas the increase observed with a higher dose was related to blockade of postsynaptic A2A receptors localized in striatopallidal neurons.

    This hypothesis was confirmed in the present study by testing the effects of the preferential presynaptic and postsynaptic A2A receptor antagonists SCH [2- 2-furanyl [3- 4-methoxyphenyl propyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidinamine] and KW [ E -1, 3-diethyl 3,4-dimethoxystyryl methyl-3,7-dihydro-1H-purine-2,6-dione], respectively, in squirrel monkeys trained to intravenously self-administer THC.

    SCH produced a significant shift to the right of the THC self- administration dose-response curves, consistent with antagonism of the reinforcing effects of THC. Conversely, KW produced a significant shift to the left, consistent with potentiation of the reinforcing effects of THC.

    These results show that selectively blocking presynaptic A2A receptors could provide a new pharmacological approach to the treatment of marijuana dependence and underscore corticostriatal glutamatergic neurotransmission as a possible main mechanism involved in the rewarding effects of THC.

    Administration of Injectable Vitamin K Orally. Vitamin K, or phytonadione, is available in both injectable and oral formulations. Oral vitamin K is available as 5-mg tablets, but the key drawbacks for using vitamin K tablets consist of availability of only 1 dose strength and recent tripling of the product's cost over a 2-year period. An interest exists for utilization of injectable vitamin K via oral route.

    A literature search was performed on April 26, , to identify any studies describing the use of injectable vitamin K for oral administration. The search involved PubMed and Embase and utilized various combinations of keywords vitamin K , phytonadione , IV , intravenous , injectable , and oral.

    The results were limited to studies that discussed oral administration of injectable vitamin K. The efficacy of the injectable preparation of vitamin K administered orally was explored in 6 studies and one cost-savings project. Based on the available literature, the administration of injectable vitamin K via oral route is effective and safe. Injectable vitamin K for oral administration can be prepared as an undiluted solution or as a compounded solution.

    These 2 formulations have different beyond-use dates depending on ingredients used. Information on efficacy and stability of injectable vitamin K formulations prepared for oral administration provides an additional option for health care systems when vitamin K tablets are unavailable or cost-prohibitive to use.

    This final rule adopts without changes an interim final rule with request for comments published in the Federal Register on March 23, Palatability and oral cavity tolerability of THC: CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: CBD oromucosal spray to mitigate these effects. Patient comfort, satisfaction and treatment adherence may benefit from these interventions.

    Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Cannabis smokers provided written informed consent to participate in this randomized, controlled, double-blind, double-dummy institutional review board-approved study. Participants received 5 and 15 mg synthetic oral THC , low-dose 5.

    Nine cannabis smokers completed all 5 dosing sessions. Relative bioavailability was calculated to determine the relative rate and extent of THC absorption; 5 and 15 mg oral THC bioavailability was These data suggest that CBD modulation of THC 's effects is not due to a pharmacokinetic interaction at these therapeutic doses. Identification of Recent Cannabis Intake. Additionally, while smoking is the most common administration route, vaporization and edibles are frequently used.

    We characterized blood pharmacokinetics of THC , its phase I and phase II glucuronide metabolites, and minor cannabinoids in occasional and frequent cannabis smokers for 54 occasional and 72 frequent hours after controlled smoked, vaporized, and oral cannabis administration. CBG and CBN were frequently identified after inhalation routes with short detection windows, but not detected following oral dosing. Vaporization and smoking provide comparable cannabinoid delivery. CBG and CBN are recent-use cannabis markers after cannabis inhalation, but their absence does not exclude recent use.

    Multiple, complimentary criteria should be implemented in conjunction with impairment observations to improve interpretation of cannabinoid tests. METHODS Cannabis smokers provided written informed consent to participate in this randomized, controlled, double-blind, double-dummy institutional review board—approved study.

    Application to hair and oral fluid analysis. Formation of picolinic acid esters of hydroxylated drugs or their biotransformation products is a promising tool to improve their mass spectrometric ionization efficiency, alter their fragmentation behaviour and enhance sensitivity and specificity of their detection. The procedure was optimized and tested for the detection of cannabinoids, which proved to be most challenging when dealing with alternative specimens, for example hair and oral fluid.

    In particular, the detection of the THC metabolites hydroxyl- THC and carboxy- THC requires ultimate sensitivity because of their poor incorporation into hair or saliva. Both biotransformation products are widely accepted as incorporation markers to distinguish drug consumption from passive contamination.

    Resulting derivatives were found to be very stable and could be reconstituted in aqueous or organic buffers and subsequently analyzed by liquid chromatography-mass spectrometry LC-MS.

    Owing to the complex consecutive fragmentation patterns, the application of multistage MS3 proved to be extremely useful for a sensitive identification of doubly picolinated hydroxy- THC in complex matrices.

    The detection limits - estimated by comparison of corresponding signal-to-noise ratios - increased by a factor of following picolination. All other species examined, like cannabinol, THC , cannabidiol, and carboxy- THC , could also be derivatized exhibiting only moderate sensitivity improvements. The assay was systematically tested using hair samples and exemplarily applied to oral fluid.

    Voluntary Oral Administration of Losartan in Rats. Gavage is a widely performed technique for daily dosing in laboratory rodents. Although effective, gavage comprises a sequence of potentially stressful procedures for laboratory animals that may introduce bias into experimental results, especially when the drugs to be tested interfere with stress-dependent parameters.

    We aimed to test vehicles suitable for drug delivery by voluntary ingestion in rats. Specifically, Male Wistar rats age, 2 to 3 mo were used to test nut paste NUT , peanut butter PB , and sugar paste SUG as vehicles for long-term voluntary oral administration of losartan, an angiotensin II receptor blocker. Vehicles were administered for 28 d without drug to assess effects on the glucose level and serum lipid profile. Losartan was mixed with vehicles and either offered to the rats or administered by gavage 14 d for subsequent quantification of losartan plasma levels by HPLC.

    After a 2-d acclimation period, all rats voluntarily ate the vehicles, either alone or mixed with losartan. NUT administration reduced blood glucose levels.

    The SUG group had higher concentrations of losartan than did the gavage group, without changes in lipid and glucose profiles. Drug bioavailability was not reduced after voluntary ingestion, suggesting that this method is highly effective for chronic oral administration of losartan to laboratory rodents. Agonist replacement treatment is a promising strategy to manage cannabis-use disorders.

    Subjects completed the multiple-choice procedure to assess drug reinforcement, and self-report, task performance and physiological measures were collected. Nabilone alone also elevated heart rate.

    These results replicate a previous study demonstrating that nabilone shares agonist effects with the active constituent of cannabis in cannabis users, and contribute further by indicating that nabilone would likely be safe and well tolerated when combined with cannabis.

    These data support the conduct of future studies to determine if nabilone treatment would produce cross-tolerance to the abuse-related effects of cannabis and reduce cannabis use. Repeated administration of all drugs resulted in tolerance to hypothermic effects, but not locomotor effects, and this tolerance was still evident 14 days after the last drug administration.

    Further studies treated mice with Select brain regions from chronically treated mice were examined for changes in CB1 receptor expression and function. Expression and function of hypothalamic CB1Rs were reduced in mice receiving chronic drugs, but cortical CB1R expression and function were not altered.

    Self-report, task performance and physiological measures were also collected. These results suggest that one mechanism by which gabapentin might facilitate cannabis abstinence is by producing effects that overlap with those of cannabinoids. Changes on metabolic parameters induced by acute cannabinoid administration CBD, THC in a rat experimental model of nutritional vitamin A deficiency. Vitamin A deficiency can result from malnutrition, malabsorption of vitamin A, impaired vitamin metabolism associated with liver disease, or chronic debilitating diseases like HIV infection or cancer.

    Cannabis administration has been described as a palliative symptom management therapy in such pathological stages. Therefore, this research aimed to study the effects of acute administration of cannabidiol CBD or thetrahydrocannabinol THC on the levels of retinol in plasma and in the liver, and biochemical parameters related to lipid and glucose metabolism cholesterolaemia, triglyceridemia and glycemia in a rat experimental model of vitamin A deficiency.

    The experimental animal model of Vitamin A deficiency was developed during a day experimental period in which rats consumed a vitamin A-free diet. The nutritional deficiency caused a significant decrease in plasmatic and liver contents of retinol and biochemical parameters of glycemic, lipidic, and mineral metabolism.

    Acute intraperitoneal administration of Cannabidiol and thetrahydrocannabinol did not improve the indices of vitamin A status in either control or vitamin A-deficient rats. However, it had a significant effect on specific biochemical parameters such as glucose, triglycerides, and cholesterol.

    Under our experimental conditions, the reported effects of cannabinoid administration on certain signs of nutritional vitamin A deficiency appeared to be mediated through mechanisms other than changes in retinol metabolism or its mobilization after the acute administration of such compounds. Background Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids.

    Cannabidiol CBD has been shown to have anxiolytic and antipsychotic effects with high doses administered orally. Conclusions While THC administration by vaporisation is increasingly adopted in experimental studies, often with oral predosing with CBD to examine interactive effects, no studies to date have reported the administration of CBD by vaporisation.

    We report the detailed methodology aimed at optimising the efficiency of delivery of therapeutic doses of CBD, alone and in combination with THC , by vaporisation.

    These protocols provide a technical advance that may inform methodology for clinical trials in humans, especially for examining interactions between THC and CBD and for therapeutic applications of CBD.

    Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Six confirmatory studies examined the quantity of each compound delivered when mg or 4 mg CBD was loaded together with 8 mg of THC.

    We describe optimised protocols that enable delivery of mg CBD through vaporisation. While THC administration by vaporisation is increasingly adopted in experimental studies, often with oral predosing with CBD to examine interactive effects, no studies to date have reported the administration of CBD by vaporisation. Marijuana is the most commonly abused illicit drug worldwide. Marijuana is used for its euphoric and relaxing properties.

    However, marijuana use has been shown to result in impaired memory, cognitive skills and psychomotor function. However, the postmortem distribution of cannabinoids has not been well characterized. Specimens evaluated, when available, included: Qualitative cannabinoid results within each case were comparable between blood and non-blood specimens. However, there was no consistent distribution of the cannabinoids between blood and any other fluids or tissues.

    Published by Oxford University Press This work is written by a US. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration. However, the oral consumption of the molecules is very limited due to their highly lipophilic nature that leads to poor solubility at the aqueous environment.

    These absorption obstacles render the molecules with low and variable oral bioavailability. To overcome these limitations we designed and developed the advanced pro-nanolipospheres PNL formulation.

    The PNL delivery system is comprised of a medium chain triglyceride, surfactants, a co-solvent and the unique addition of a natural absorption enhancer: Piperine was selected due to its distinctive inhibitory properties affecting both Phase I and Phase II metabolism.

    This constellation self emulsifies into nano particles that entrap the cannabinoids and the piperine in their core and thus improve their solubility while piperine and the other PNL excipients inhibit their intestinal metabolism. Another clear advantage of the formulation is that its composition of materials is approved for human consumption. The safe nature of the excipients enabled their direct evaluation in humans.

    The trial comprised of 9 healthy volunteers under fasted conditions. Single oral administration of the piperine-PNL formulation resulted in a 3-fold increase in Cmax and a 1. For CBD, a 4-fold increase in Cmax and a 2. These findings demonstrate the potential this formulation has.

    Deuterated d3 internal standards were added to 1-mL samples. Preparation involved acetonitrile precipitation, liquid-liquid extraction hexane: Selected reaction monitoring was employed. Blood samples were provided from a marijuana smoking study two participants and a CBD ingestion study eight participants. Preparation involved acetonitrile precipitation, liquid—liquid extraction hexane: How cannabis causes paranoia: Paranoia is receiving increasing attention in its own right, since it is a central experience of psychotic disorders and a marker of the health of a society.

    Paranoia is associated with use of the most commonly taken illicit drug, cannabis. A randomized, placebo-controlled, between-groups test of the effects of intravenous THC was conducted. A total of individuals with paranoid ideation were randomized to receive placebo, THC , or THC preceded by a cognitive awareness condition. Paranoia was assessed extensively via a real social situation, an immersive virtual reality experiment, and standard self-report and interviewer measures.

    Putative causal factors were assessed. Principal components analysis was used to create a composite paranoia score and composite causal variables to be tested in a mediation analysis. THC significantly increased paranoia, negative affect anxiety, worry, depression, negative thoughts about the self , and a range of anomalous experiences, and reduced working memory capacity.

    The increase in negative affect and in anomalous experiences fully accounted for the increase in paranoia. Working memory changes did not lead to paranoia. Making participants aware of the effects of THC had little impact. In this largest study of intravenous THC , it was definitively demonstrated that the drug triggers paranoid thoughts in vulnerable individuals. The most likely mechanism of action causing paranoia was the generation of negative affect and anomalous experiences.

    How Cannabis Causes Paranoia: Comparing treatment effects of oral THC on simulated and on-the-road driving performance: The driving simulator provides a safe and controlled environment for testing driving behaviour efficiently. The question is whether it is sensitive to detect drug-induced effects. The primary aim of the current study was to investigate the sensitivity of the driving simulator for detecting drug effects.

    Dose-related effects of the drug on the ability to keep a vehicle in lane weaving and to follow the speed changes of a lead car car following were compared within subjects for on-the-road versus in-simulator driving. Additionally, the outcomes of equivalence testing to alcohol-induced effects were investigated. Treatment effects found on weaving when driving in the simulator were comparable to treatment effects found when driving on the road.

    The effect after 10 mg dronabinol was however less strong in the simulator than on the road and inter-individual variance seemed higher in the simulator. There was, however, a differential treatment effect of dronabinol on reactions to speed changes of a lead car car following when driving on the road versus when driving in the simulator.

    The driving simulator was proven to be sensitive for demonstrating dronabinol-induced effects particularly at higher doses. Treatment effects of dronabinol on weaving were comparable with driving on the road but inter-individual variability seemed higher in the simulator than on the road which may have potential effects on the clinical inferences made from simulator driving.

    Car following on the road and in the simulator were, however, not comparable. CBD potentiated an inhibition of body weight gain caused by chronic THC , and mildly augmented the anxiogenic effects, locomotor suppressant effects and decreased social interaction seen with THC.

    CBD can potentiate the psychoactive and physiological effects of THC in rats, most likely by delaying the metabolism and elimination of THC through an action on the CYP enzymes that metabolise both drugs. The majority of MDMA ecstasy recreational users also consume cannabis. Despite the rewarding effects that both drugs have, they induce several opposite pharmacological responses.

    MDMA causes hyperthermia, oxidative stress and neuronal damage, especially at warm ambient temperature. However, THC , the main psychoactive compound of cannabis, produces hypothermic, anti-inflammatory and antioxidant effects.

    Surprisingly, MDMA-induced DA terminal loss was only observed in animals housed at warm but not at room temperature, and this neurotoxic effect was reversed by THC administration. Our results indicate that THC protects against MDMA neurotoxicity, and suggest that these neuroprotective actions are primarily mediated by the reduction of hyperthermia through the activation of CB 1 receptor, although CB 2 receptors may also contribute to.

    Our results indicate that THC protects against MDMA neurotoxicity, and suggest that these neuroprotective actions are primarily mediated by the reduction of hyperthermia through the activation of CB1 receptor, although CB2 receptors may also contribute to attenuate neuroinflammation in this.

    Acute effects of THC on time perception in frequent and infrequent cannabis users. Cannabinoids have been shown to alter time perception, but existing literature has several limitations. Our study attempted to address these limitations. This study aims to characterize the acute effects of THC and frequent cannabis use on seconds-range time perception. THC was hypothesized to produce transient, dose-related time overestimation and underproduction.

    Frequent cannabis smokers were hypothesized to show blunted responses to these alterations. IV THC was administered at doses from 0. Visual time estimation and production tasks in the seconds range were presented to subjects three times on each test day. All doses induced time overestimation and underproduction.

    Chronic cannabis use had no effect on baseline time perception. THC effects on time perception were not dose related.

    A psychoactive dose of THC increases internal clock speed as indicated by time overestimation and underproduction. This effect is not dose related and is blunted in chronic cannabis smokers who did not otherwise have altered baseline time perception. The effect of five day dosing with THCV on THC -induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial. To explore the safety and tolerability of repeated THCV administration and its effects on symptoms normally induced by THC in a sample of healthy volunteers.

    Ten male cannabis users oral pure THCV or placebo were administered daily for five days, followed by 1mg intravenous THC on the fifth day. THCV was well tolerated and subjectively indistinguishable from placebo. THC did not significantly increase psychotic symptoms, paranoia or impair short-term memory, while still producing significant intoxicating effects.

    These findings need to be interpreted with caution due to a small sample size and lack of THC -induced psychotomimetic and memory-impairing effect, probably owing to the choice of dose. Interactions between these two drugs have been reported in several pharmacological responses observed in animals, such as body temperature, anxiety, cognition, and reward.

    However, the interaction between MDMA and cannabis in addictive processes such as physical dependence has not been elucidated yet. In this study, the effects of acute and chronic MDMA were evaluated on the behavioral manifestations of Delta 9 -tetrahydrocannabinol THC abstinence in mice. Our results also indicate that the attenuation of THC abstinence symptoms was not due to a direct interaction between rimonabant and MDMA nor to the result of the locomotor stimulating effects of MDMA.

    The modulation of the cannabinoid withdrawal syndrome by acute or chronic MDMA suggests a possible mechanism to explain the associated consumption of these two drugs in humans.

    Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Although smoking is the most common cannabis administration route, vaporization and consumption of cannabis edibles are common.

    Few studies directly compare cannabis' subjective and physiological effects following multiple administration routes. Subjective and physiological effects, and expired carbon monoxide CO were evaluated in frequent and occasional cannabis users following placebo 0. Participants' subjective ratings were significantly elevated compared to placebo after smoking and vaporization, while only occasional smokers' ratings were significantly elevated compared to placebo after oral dosing.

    Frequent smokers' maximum ratings were significantly different between inhaled and oral routes, while no differences in occasional smokers' maximum ratings between active routes were observed. Additionally, heart rate increases above baseline 0. Finally, smoking produced significantly increased expired CO concentrations 0.

    All participants had significant elevations in subjective effects after smoking and vaporization, but only occasional smokers after oral cannabis, indicating partial tolerance to subjective effects with frequent exposure. There were no differences in occasional smokers' maximum subjective ratings across the three active administration routes. Vaporized cannabis is an attractive alternative for medicinal administrations over smoking or oral routes; effects occur quickly and doses can be titrated with minimal CO exposure.

    These results have strong implications for safety and abuse liability assessments. Published by Elsevier B. Pharmacokinetics of paracetamol acetaminophen after intravenous and oral administration.

    Plasma paracetamol concentrations were measured in 6 volunteers after single intravenous mg and oral mg, mg and mg doses of the drug. A two-compartment open model appeared to describe the decline adequately. Comparison of the areas under the plasma concentration-time curves AUC indicated that oral bioavailability increased from 0. As a consequence of the incomplete bioavailability of paracetamol, as well as its multicompartmental distribution, accurate estimates of its distribution volume and clearance cannot be obtained if the drug is given orally.

    However, an estimate of its total plasma clearance may be derived from the AUC after a mg oral dose. The authors aimed to determine the effects of short-term 6 days treatment with guanfacine on adverse cognitive effects produced by THC. Employing a double-blind, placebo-controlled crossover design, the cognitive, subjective, and cardiovascular effects produced by oral THC 20 mg administration were determined twice in the same cannabis users: Although THC increased visual analog scores of subjective effects and heart rate, these increases were similar during treatment with placebo and guanfacine.

    THC did not significantly affect performance of a recognition memory task or blood pressure while individuals were maintained on either treatment. Although preliminary, these results suggest that guanfacine warrants further testing as a potential treatment for cannabis-induced cognitive deficits.

    Pharmacokinetics of tilmicosin after oral administration in swine. To determine the pharmacokinetics of tilmicosin after oral administration of a single dose of tilmicosin base in swine. Blood samples were obtained from a jugular vein immediately before and at 10, 20, and 30 minutes and 1, 2, 3, 4, 6, 8, 12, 24, 36, 48, 72, 96, and hours after administration of tilmicosin.

    Tilmicosin concentrations in serum were quantified by use of a high-performance liquid chromatography procedure with UV light. Data for tilmicosin concentrations versus time were analyzed by use of compartmental and noncompartmental methods. Tilmicosin concentrations in serum decreased in a biexponential manner after oral administration.

    In swine, tilmicosin was rapidly absorbed and slowly eliminated after oral administration of a single dose of tilmicosin base powder. Long term stability of cannabinoids in oral fluid after controlled cannabis administration. Cannabinoid stability in oral fluid OF is important for assuring accurate results since OF has become a valid alternative matrix of choice for drug testing.

    Extending refrigerated stability up to 3 months would be helpful for clinical and forensic testing, for reanalysis of OF samples and for batching research analyses. Individual authentic OF pools were prepared after controlled smoking of a 6.

    Fifteen healthy volunteers participated in the Institutional Review Board approved study. Baseline concentrations were highly variable. Pharmacokinetics of valproic acid after oral and intravenous administration. In all subjects absorption was rapid and complete. Half-lives ranged from h. Apparent volumes of distribution were relatively low 0. Azathioprine pharmacokinetics after intravenous, oral , delayed release oral and rectal foam administration.

    However, use of these drugs has been limited by concerns about their toxicity. Colonic delivery of azathioprine may reduce its systemic bioavailability and limit toxicity. To determine the bioavailability of 6-mercaptopurine after administration of azathioprine via three colonic delivery formulations. All subjects also received a 50 mg dose of intravenous azathioprine during a separate study period.

    Plasma concentrations of 6-mercaptopurine were determined by high pressure liquid chromatography. Azathioprine delivered to the colon by delayed release oral and rectal foam formulations considerably reduced systemic 6-mercaptopurine bioavailability. The therapeutic potential of these colonic delivery methods, which can potentially limit toxicity by local delivery of high doses of azathioprine, should be investigated in patients with inflammatory bowel disease.

    Anti-cancer activity of bromelain nanoparticles by oral administration. Oral administration of anti-cancer drugs is an effective alternative to improve their efficacy and reduce undesired toxicity. Bromelain BL is known as an effective anti-cancer phyto-therapeutic agent, however, its activity is reduced upon oral administration. Further, the NPs were coated with Eudragit L30D polymer to introduce stability against the gastric acidic conditions.

    The resultant coated NPs were characterized for BL entrapment, proteolytic activity and mean particle size. Cytotoxicity studies carried out in human cell lines of diverse origin have shown significant dose advantage folds with NPs in reducing the IC50 values compared with free BL. Altered expression of marker proteins associated with apoptosis and cell death P53, P21, Bcl2, Bax also confirmed the enhanced anti-carcinogenic potential of formulated NPs.

    Oral administration of NPs reduced the tumor burden of Ehrlich ascites carcinoma EAC in Swiss albino mice and also increased their life-span The generation of reactive oxygen species, induction of apoptosis and impaired mitochondrial membrane potential in EAC cells treated with NPs confirmed the suitability of Eudragit coated BL-NPs as a promising candidate for oral chemotherapy. Pharmacokinetic Profile of Oral Cannabis in Humans: Vandrey, Ryan; Herrmann, Evan S.

    Whole blood and oral fluid specimens were obtained at baseline and then for 9 days post-exposure; 6 days in a residential research setting and 3 days as outpatients. Measures of subjective, cardiovascular and performance effects were obtained at baseline and for 8 h post-ingestion.

    The mean Cmax for THC in whole blood was 1, 3. The mean Tmax for THC in oral fluid occurred immediately following oral dose administration , and appear to reflect local topical residue rather than systemic bioavailbility. Subjective drug and cognitive performance effects were generally dose dependent, peaked at 1.

    Whole blood cannabinoid concentrations were significantly correlated with subjective drug effects. Correlations between blood cannabinoids and cognitive performance measures, and between oral fluid and all pharmacodynamic outcomes were either non-significant or not orderly by dose. Quantitative levels of cannabinoids in whole blood and oral fluid were low compared with levels observed following.

    Most research on cannabis pharmacokinetics has evaluated inhaled cannabis, but oral "edible" preparations comprise an increasing segment of the cannabis market. Quantitative levels of cannabinoids in whole blood and oral fluid were low compared with levels observed following inhalation of. Brain kinetics of methylphenidate Ritalin enantiomers after oral administration. It is a chiral drug, marketed as the racemic mixture of d- and l-threo enantiomers. Inflammation is to blame for nearly every ailment, from allergies to cancer.

    In turn, this will also help to manage and prevent associated pain and distress. Another way that CBD can help both you and your feline friend is in cases of anxiety. CBD oil can also be used to treat a number of different phobias from separation anxiety to a fear of loud noises such as fireworks.

    They will simply be able to live anxiety-free lives with the help of CBD. Remarkably, CBD oil is proving to be effective in people and animals who suffer from epilepsy. Studies show that CBD oil can effectively reduce the severity and frequency of seizures.

    Even more good news? CBD oil has proven to work in cases where the individual and cat were resistant to conventional anti-seizure drugs. You read that correctly! CBD works in cases were harsh medications failed. Many studies show that CBD is actually effective at killing cancer cells.

    This is due to its anti-tumor effect and anti-inflammatory properties. Of course, more research is being done on the topic and we are still far from completely negating the need for conventional cancer treatments.

    However, it is comforting to know that all natural alternatives are continuing to prove their effectiveness and worth. In cases where cats must undergo cancer treatments such as chemotherapy or radiation, CBD can be a great tool to help lessen the associated side effects of the treatment.

    Chemotherapy can cause a loss of appetite as well as bouts of diarrhea and vomiting in both cats and dogs. CBD oil can help boost the appetite back to normal and also provide gastrointestinal support. Inflammatory bowel disease in cats can present a slew of issues including side effects such as vomiting, diarrhea, and weight loss.

    Due to its anti-inflammatory properties, CBD oil can not only help reverse the disease, but also alleviate the uncomfortable side effects of IBD. Again, due to its anti-inflammatory properties, CBD oil is incredibly effective when it comes to allergy relief. Our furry animals tend to show signs of allergies in different ways than they affect people.

    Primarily, skin irritations and poor coat quality are two telltale signs of allergies in our pets. CBD is a great way to help! Additionally, one of our favorite companies produces specially formulated CBD treats for alleviating environmental allergies in cats and dogs. This also is true of how cats react to newsupplements, including CBD oil. In the vast majority of cases, CBD oil has virtually zero side effects. In some cases, a mild sedation may occur.

    However, if this happens, simply lower the dosage of CBD oil that you administer to your kitty. Again, CBD oil for cats is proven to be extremely safe when the oil that they are given is derived from the hemp plant. Under no occasion should pet parents give their cat marijuana-derived oils. Marijuana oil and smoke can cause your cat to experience a slew of adverse reactions. Trust us, it will not make them calm down or help with any medical problems.

    Always avoid oils derived from the marijuana plant when it comes to your dogs and cats. When it comes to CBD oil for cats, we like to think that less is more. Holistic experts suggest a starting dose of 1 mg — 5 mg per 10 lbs. Therefore, dosages typically start off with mg, depending on how much your cat weighs. An awesome holistic veterinarian named Dr. Angie Krause recommends the following CBD dosages for varying ailments.

    For more information on Dr. This is the same receptor that is triggered when you eat a habanero pepper or something with spice. The cannabis plant has over 60 chemicals called cannabinoids. At this level, cannabis has no intoxicating effect, for people or dogs. The cannabis plant contains a number of different chemicals, including CBD, phytocannabinoids, terpenoids and flavonoids. Humans and other mammals have specific cannabinoid receptor sites.

    These sites are primarily in the brain and central nervous system, and in peripheral organs, especially immune cells. Studies show that many cannabinoids have anti-inflammatory effects, and can help with pain, tumors, seizures, muscle spasms, skin conditions, appetite stimulation, aggression, anxiety and neurological disorders.

    Among chronic conditions, it can help with arthritis, compromised immune systems, stress responses, aggression and digestive issues. Veterinarians are also finding CBD oil can be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness.

    Since conventional medicines do have side effects, this is a useful benefit of CBD. As with any herbal medicine, for most ailments you may not see an immediate effect. Your dog may feel some pain relief in a few hours but other symptoms like inflammation may take a few days to show improvement. The most common side effect of CBD is that your dog may get a little drowsy — about the same as if you gave him a Benadryl. On rare occasions, side effects have included excessive itchiness or mild vomiting, but these sensitivities are few and far between.

    If your dog reacts with these symptoms, you should stop giving him cannabis. If this happens to your dog, take him to the vet immediately. Please take time out of your day to learn more about CBD Oil. Amazing potential for health and business.

    CBD Oil for Cats: Everything You Need To Know

    Methods: Single-dose pharmacokinetics was performed using two different doses of Objectives: The objectives of this study were to determine basic oral Dogs received each of two treatments: CBD oil (2 mg/kg) or placebo oil every 12 h. .. clinical trial at 2 mg/kg body weight every 12 h, due the cost. Each bottle delivers mg of CBD to promote calmness, boost appetite, A general rule for one serving size is three drops of CBD oil for every 10 pounds (or 5kg) To accurately calculate your cat's serving size, you'll need your cat's weight. .. on 1 drop twice a day and worked up to the recommended dose for her wei. mice, decreases in body weight, nervous system effects, lower sperm (BMDL10 ) of mg Δ9-THC/kg b.w. per day for the increased length in Therefore, basic . cannabinoids in hemp food products, such as Δ9-THC, CBD, and CBN. 2 to 3 days in i.v. dosed rabbits (Leuschner et al., ), 8 days in dogs after i.v.

    Which CBD oil for your entire family does Dr Blake and his friends Yin and Yang recommend?



    Methods: Single-dose pharmacokinetics was performed using two different doses of Objectives: The objectives of this study were to determine basic oral Dogs received each of two treatments: CBD oil (2 mg/kg) or placebo oil every 12 h. .. clinical trial at 2 mg/kg body weight every 12 h, due the cost.


    Each bottle delivers mg of CBD to promote calmness, boost appetite, A general rule for one serving size is three drops of CBD oil for every 10 pounds (or 5kg) To accurately calculate your cat's serving size, you'll need your cat's weight. .. on 1 drop twice a day and worked up to the recommended dose for her wei.


    mice, decreases in body weight, nervous system effects, lower sperm (BMDL10 ) of mg Δ9-THC/kg b.w. per day for the increased length in Therefore, basic . cannabinoids in hemp food products, such as Δ9-THC, CBD, and CBN. 2 to 3 days in i.v. dosed rabbits (Leuschner et al., ), 8 days in dogs after i.v.


    Oral THC 10 mg or CBD mg or placebo was administered in three .. within h after a single oral THC dose and throughout multiple dosing, respectively. .. with vehicle, 10 or 20 mg THC/kg body weight daily, 5 days/week for 90 days. pharmacokinetics of QN after i.v. and oral administration in beagle dogs.

    Add Comment